Minapharm Pharmaceuticals MIPH
مينا فارم للأدوية والصناعات الكيماوية
Health Care & PharmaceuticalsEgyptian Exchange
798.89 EGP
-1.37%
Close of Thu 12 Nov 2026
- Market value
- EGP 9.17bn
- Highest and lowest close in a year
- 310.35 – 941.03
- Shares traded in the session
- 2,557
A chart of every session, the financial statements, the nine checks and filing alerts. Free, with your e-mail and a six-digit code.
About the company
Established in October 1986 and based in Cairo, Egypt, Minapharm Pharmaceuticals is a pharmaceuticals, biotechnology, and life sciences company focusing on pharmaceuticals. Listed on the Egyptian Exchange since January 2004, it is controlled by TRIQUEAR B.V, which held 83.3151% as of June 2026. Its subsidiaries include ProBioGen AG (99.19%), Minapharm for Trade and Distribution (95.0%), Migentra Egypt Healthcare Transforming Medicines (75.01%), and MiGenTra- GmbH (49.0%).
Its record at the exchange
Minapharm Pharmaceuticals has 582 filings from 2010 to 2026, peaking in 2022 with 58 filings. Trading was suspended and resumed 9 times. Across 63 reported periods from 2013 to 2026, 3 were loss-making. Its highest full-year net result was 631 million EGP in FY 2022, while its lowest was 22 million EGP in FY 2023. On 2026-02-03, it executed its first capital decrease in 11 years via treasury stock cancellation.
Its latest filings at the exchange
- Board decisionsMinapharm Pharmaceuticals (MIPH.CA) - Disclosure Form for the Board of Directors and Shareholders' Structure
- Auditor or accountsMinapharm Pharmaceuticals (MIPH.CA) - Company's Response to the Auditor's Report
- ResultsMinapharm Pharmaceuticals (MIPH.CA) Reports 6 Months Consolidated Results
- Board decisionsMinapharm Pharmaceuticals (MIPH.CA) - Minutes of the BoD Meeting
- Board decisionsMinapharm Pharmaceuticals (MIPH.CA) - Minutes of the Board of Directors' Meeting
- ResultsMinapharm Pharmaceuticals (MIPH.CA) Reports Its Financial Results (Standalone) for The Period From 01/01/2026 to 30/06/2026
- Release from Minapharm Pharmaceuticals (MIPH.CA)
- Auditor or accountsMinapharm Pharmaceuticals (MIPH.CA) - Company's Response to the Auditor's Report
Insider trades in the exchange’s bulletin
As the exchange publishes them in each session’s bulletin: the trader’s capacity, not their name. Each row opens the bulletin itself.
- Insider / Board Bought983 (less than 0.01% of the company)Bulletin ↗
- Insider / Board Bought5,306 (0.05% of the company)Bulletin ↗
- Insider / Board Sold10,790 (0.09% of the company)Bulletin ↗
- Insider / Board Bought10,790 (0.09% of the company)Bulletin ↗
- Insider / Board Sold11,000 (0.09% of the company)Bulletin ↗
- Insider / Board Bought11,000 (0.09% of the company)Bulletin ↗
- Insider / Board Sold1 (less than 0.01% of the company)Bulletin ↗
- Insider / Board Bought1,647 (0.01% of the company)Bulletin ↗
- Insider / Board Bought1 (less than 0.01% of the company)Bulletin ↗
- Insider / Board Bought7,220 (0.06% of the company)Bulletin ↗
Other companies in Health Care & Pharmaceuticals
- GlaxoSmithKline S.A.E. BIOC
- Cleopatra Hospital Company CLHO
- Egyptian International Pharmaceutical Industries Co. PHAR
- El-Nile Co. for Pharmaceuticals & Chemical Industries NIPH
- Alexandria New Medical Center Co. AMES
- Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda RMDA
- Ibnsina Pharma ISPH
- Kahira Pharmaceuticals & Chemical Industries Co. CPCI
- Memphis Pharmaceutical & Chemical Industries MPCI
- Alexandria Company for Pharmaceuticals and Chemical Industries AXPH
- Nozha International Hospital NINH
- October Pharma Co. OCPH
Page updated with the data of 15 Nov 2026.